AlphaCentric Advisors LLC Purchases Shares of 39,299 Inotiv, Inc. (NASDAQ:NOTV)

AlphaCentric Advisors LLC acquired a new position in shares of Inotiv, Inc. (NASDAQ:NOTVFree Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 39,299 shares of the company’s stock, valued at approximately $163,000.

Several other large investors also recently made changes to their positions in NOTV. Geode Capital Management LLC lifted its stake in Inotiv by 7.7% in the 3rd quarter. Geode Capital Management LLC now owns 250,895 shares of the company’s stock valued at $427,000 after purchasing an additional 18,039 shares during the last quarter. Thurston Springer Miller Herd & Titak Inc. raised its stake in Inotiv by 612.5% in the fourth quarter. Thurston Springer Miller Herd & Titak Inc. now owns 127,257 shares of the company’s stock valued at $527,000 after buying an additional 109,397 shares during the period. KPP Advisory Services LLC lifted its position in shares of Inotiv by 15.8% in the fourth quarter. KPP Advisory Services LLC now owns 275,267 shares of the company’s stock valued at $1,140,000 after buying an additional 37,549 shares during the last quarter. Vantage Point Financial LLC acquired a new stake in shares of Inotiv in the fourth quarter valued at approximately $1,393,000. Finally, Calamos Advisors LLC bought a new position in shares of Inotiv during the 4th quarter worth approximately $275,000. Institutional investors and hedge funds own 18.17% of the company’s stock.

Insider Buying and Selling at Inotiv

In other Inotiv news, CEO Robert Jr. Leasure sold 22,700 shares of Inotiv stock in a transaction dated Friday, January 31st. The stock was sold at an average price of $4.15, for a total value of $94,205.00. Following the transaction, the chief executive officer now owns 1,030,209 shares in the company, valued at $4,275,367.35. The trade was a 2.16 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, COO John Gregory Beattie purchased 30,000 shares of Inotiv stock in a transaction dated Tuesday, December 10th. The stock was bought at an average price of $4.75 per share, for a total transaction of $142,500.00. Following the completion of the purchase, the chief operating officer now owns 161,761 shares in the company, valued at $768,364.75. This represents a 22.77 % increase in their position. The disclosure for this purchase can be found here. In the last quarter, insiders acquired 71,029 shares of company stock valued at $314,248 and sold 26,872 shares valued at $112,854. Insiders own 7.80% of the company’s stock.

Inotiv Stock Up 1.1 %

NOTV opened at $3.78 on Tuesday. The stock’s fifty day simple moving average is $4.42 and its 200 day simple moving average is $2.91. Inotiv, Inc. has a 1-year low of $1.23 and a 1-year high of $11.42. The stock has a market cap of $98.32 million, a PE ratio of -0.82 and a beta of 3.58. The company has a current ratio of 1.37, a quick ratio of 1.22 and a debt-to-equity ratio of 2.29.

Inotiv (NASDAQ:NOTVGet Free Report) last posted its earnings results on Wednesday, February 5th. The company reported ($0.42) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.32) by ($0.10). Inotiv had a negative return on equity of 15.07% and a negative net margin of 25.40%. As a group, research analysts expect that Inotiv, Inc. will post -0.73 earnings per share for the current year.

Inotiv Profile

(Free Report)

Inotiv, Inc provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries. It operates through two segment: Discovery and Safety Assessment (DSA), and Research Models and Services (RMS). The DMS segment manufactured scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the Company's BASi product line.

See Also

Want to see what other hedge funds are holding NOTV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Inotiv, Inc. (NASDAQ:NOTVFree Report).

Institutional Ownership by Quarter for Inotiv (NASDAQ:NOTV)

Receive News & Ratings for Inotiv Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inotiv and related companies with MarketBeat.com's FREE daily email newsletter.